PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60

Detalles Bibliográficos
Autores principales: Parovichnikova, Elena, Lukianova, Irina, Galtzeva, Irina, Kashlakova, Anastasiya, Fidarova, Zalina, Aleshina, Olga, Kuzmina, Larisa, Troitskaya, Vera, Drokov, Mikhail, Sokolov, Andrey, Bondarenko, Sergej, Samoilova, Olga, Grishunina, Mariya, Konstantinova, Tatiana, Sveshnikova, Yuliya, Minaeva, Natalia, Zinina, Elena, Lapin, Valerij, Kaplanov, Kamil, Gritsaev, Sergej, Gribanova, Elena, Dvirnyk, Valentina, Obukhova, Tatiana, Sudarikov, Andrej, Chabaeva, Yuliya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430313/
http://dx.doi.org/10.1097/01.HS9.0000974300.64022.c0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430313/
http://dx.doi.org/10.1097/01.HS9.0000974300.64022.c0

Ejemplares similares